The analysis of clinical samples showed that mTORC1 was partially activated in HCC specimens compared with adjacent tissues, although this activity did not correlate with the expression of c‐Myc or glutamine transporters or with GLS1/GLS2 protein levels. The gene discussed is GLS2; the disease is hepatocellular carcinoma.